U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06885346) titled 'Probiotics Improve Adult Allergic Rhinitis and Regulate Gut Microbiota' on March 13.
Brief Summary: Assessing the clinical efficacy of weizmannia coagulans BC99 in alleviating allergic rhinitis symptoms, improving gut microbiota, and reducing adverse reactions in patients.
Study Start Date: Nov. 02, 2024
Study Type: INTERVENTIONAL
Condition:
Allergic Rhinitis
Intervention:
DIETARY_SUPPLEMENT: Probiotic
The experimental phase of this study lasts for 8 weeks, with each patient making three visits at weeks 1, 4, and 8.
DIETARY_SUPPLEMENT: Placebo
The experimental phase of this study lasts for 8 weeks, with each patient making...